The proposed mechanism by which MTNR1B polymorphism could predispose to T2D involves altered expression of MTNR1B in pancreatic β-cells leading to decreased cAMP/cGMP concentrations via G proteins and, thereby, impaired insulin secretion. The gene discussed is INS; the disease is type 2 diabetes mellitus.